{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T04:30:17Z","timestamp":1793939417574,"version":"4.8.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001791","name":"Griffith University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001791","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and objectives<\/jats:title>\n                    <jats:p>Multiple sclerosis (MS), aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (AQP4-Ab\u2009+\u2009ve NMOSD), and myelin oligodendrocyte glycoprotein-associated disease (MOGAD) are demyelinating diseases with differing pathophysiological processes and treatments. The objective of this study was to compile a comprehensive list of MRI lesions, and to quantify the utility of these lesions in distinguishing between these conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched for articles comparing MRI lesion frequency in MS, AQP4-Ab\u2009+\u2009ve NMOSD, MOGAD and healthy controls. Bayesian network meta-analysis together with pairwise and pooled case-case comparison analyses to develop sensitivity, specificity, and positive predictive values were undertaken.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Sixty-six articles were reported on 2933 MS, 3296 AQP4-Ab\u2009+\u2009ve NMOSD, and 1559 MOGAD cases, and 561 healthy controls. MRI lesions associated with MS were: periventricular T2, subcortical white matter T2, Dawson's finger, U-fibre T2 lesion, posterior spinal column T2, inferior temporal T2, cortical T2, brain T1 hypointensity (black holes), peripheral spinal cord T2, pons T2, unilateral optic nerve T2 and brain gadolinium enhancing lesions. Optic chiasm T2, LETM, bright spotty spinal cord T2, area postrema T2, hypothalamic T2, spinal cord atrophy and optic tract T2 lesions were associated with AQP4-Ab\u2009+\u2009ve NMOSD. Conus medullaris T2, fluffy, perineural enhancement, peri-ependymal 3rd ventricle T2 and peri-ependymal 4th ventricle T2 lesions were associated with MOGAD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This review identified MRI features supportive of a diagnosis of MS, NMOSD or MOGAD, and has clarified the diagnostic utility of various MRI lesion characteristics, to aid in future clinical decision-making and guide future approaches to research.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00415-025-13303-w","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T04:16:03Z","timestamp":1754540163000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Characteristics of MRI lesions in AQP4 antibody-positive NMOSD, MOGAD, and multiple sclerosis: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"272","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8914-9941","authenticated-orcid":false,"given":"Unnah","family":"Leitner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4697-5415","authenticated-orcid":false,"given":"Sin Hong","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2655-6110","authenticated-orcid":false,"given":"Jessica","family":"Blanch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1531-7054","authenticated-orcid":false,"given":"Megha","family":"Viswanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2675-439X","authenticated-orcid":false,"given":"Sasha","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7292-9658","authenticated-orcid":false,"given":"Sandeep","family":"Bhuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3907-1127","authenticated-orcid":false,"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0097-2438","authenticated-orcid":false,"given":"Jing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9429-4307","authenticated-orcid":false,"given":"Simon A.","family":"Broadley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,7]]},"reference":[{"issue":"6","key":"13303_CR1","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.neurol.2018.02.084","volume":"174","author":"C Alves Do Rego","year":"2018","unstructured":"Alves Do Rego C, Collongues N (2018) Neuromyelitis optica spectrum disorders: features of aquaporin-4, myelin oligodendrocyte glycoprotein and double-seronegative-mediated subtypes. Rev Neurol (Paris) 174(6):458\u2013470","journal-title":"Rev Neurol (Paris)"},{"issue":"7","key":"13303_CR2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrneurol.2010.72","volume":"6","author":"S Jarius","year":"2010","unstructured":"Jarius S, Wildemann B (2010) AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance. Nat Rev Neurol 6(7):383\u2013392","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"13303_CR3","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000110","volume":"2","author":"A Zekeridou","year":"2015","unstructured":"Zekeridou A, Lennon VA (2015) Aquaporin-4 autoimmunity. Neurol - Neuroimmunol Neuroinflamm 2(4):e110","journal-title":"Neurol - Neuroimmunol Neuroinflamm"},{"issue":"2","key":"13303_CR4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T et al (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85(2):177\u2013189","journal-title":"Neurology"},{"issue":"1","key":"13303_CR5","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3390\/ijms22010100","volume":"22","author":"W Ambrosius","year":"2021","unstructured":"Ambrosius W, Michalak S, Kozubski W, Kalinowska A (2021) Myelin oligodendrocyte glycoprotein antibody-associated disease: current insights into the disease pathophysiology, diagnosis and management. Int J Mol Sci 22(1):100","journal-title":"Int J Mol Sci"},{"key":"13303_CR6","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/acn3.52310","volume":"12","author":"Y Said","year":"2025","unstructured":"Said Y, Filippatou A, Tran C, Rezavi L, Guo K, Smith MD et al (2025) Real-world clinical experience with serum MOG and AQP4 antibody testing by live versus fixed cell-based assay. Annal Clin Transl Neurol 12:556\u2013564","journal-title":"Annal Clin Transl Neurol"},{"issue":"11","key":"13303_CR7","doi-asserted-by":"crossref","first-page":"e1250","DOI":"10.1212\/WNL.0000000000007096","volume":"92","author":"PJ Waters","year":"2019","unstructured":"Waters PJ, Komorowski L, Woodhall M, Lederer S, Majed M, Fryer J et al (2019) A multicenter comparison of MOG-IgG cell-based assays. Neurology 92(11):e1250\u2013e1255","journal-title":"Neurology"},{"issue":"3","key":"13303_CR8","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/cen3.12107","volume":"5","author":"PJ Waters","year":"2014","unstructured":"Waters PJ, Pittock SJ, Bennett JL, Jarius S, Weinshenker BG, Wingerchuk DM (2014) Evaluation of aquaporin-4 antibody assays. Clin Exp Neuroimmunol 5(3):290\u2013303","journal-title":"Clin Exp Neuroimmunol"},{"issue":"3","key":"13303_CR9","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","volume":"22","author":"B Banwell","year":"2023","unstructured":"Banwell B, Bennett JL, Marignier R, Kim HJ, Brilot F, Flanagan EP et al (2023) Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD panel proposed criteria. Lancet Neurol 22(3):268\u2013282","journal-title":"Lancet Neurol"},{"issue":"2","key":"13303_CR10","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17(2):162\u2013173","journal-title":"Lancet Neurol"},{"key":"13303_CR11","volume":"12","author":"L Clarke","year":"2021","unstructured":"Clarke L, Arnett S, Bukhari W, Khalilidehkordi E, Jimenez Sanchez S, O\u2019Gorman C et al (2021) MRI patterns distinguish AQP4 antibody positive neuromyelitis optica spectrum disorder from multiple sclerosis. Front Neurol 12:722237","journal-title":"Front Neurol"},{"key":"13303_CR12","doi-asserted-by":"crossref","first-page":"n160","DOI":"10.1136\/bmj.n160","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ 372:n160","journal-title":"BMJ"},{"key":"13303_CR13","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71","journal-title":"BMJ"},{"key":"13303_CR14","first-page":"359","volume":"2006","author":"X Huang","year":"2006","unstructured":"Huang X, Lin J, Demner-Fushman D (2006) Evaluation of PICO as a knowledge representation for clinical questions. AMIA Annu Symp Proc AMIA Symp 2006:359\u2013363","journal-title":"AMIA Annu Symp Proc AMIA Symp"},{"key":"13303_CR15","volume-title":"Covidence systematic review software","author":"VH Innovation","year":"2023","unstructured":"Innovation VH (2023) Covidence systematic review software. Veritas Health Innovation, Melbourne, Australia"},{"issue":"27","key":"13303_CR16","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3310\/hta7270","volume":"7","author":"JJ Deeks","year":"2003","unstructured":"Deeks JJ, Dinnes J, D\u2019Amico R, Sowden AJ, Sakarovitch C, Song F et al (2003) Evaluating non-randomised intervention studies. Health Technol Assess 7(27):186","journal-title":"Health Technol Assess"},{"issue":"3","key":"13303_CR17","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.2517-6161.1995.tb02042.x","volume":"57","author":"BP Carlin","year":"1995","unstructured":"Carlin BP, Chib S (1995) Bayesian model choice via Markov chain Monte Carlo methods. J R Stat Soc Ser B Stat Methodol 57(3):473\u2013484","journal-title":"J R Stat Soc Ser B Stat Methodol"},{"issue":"9","key":"13303_CR18","volume":"9","author":"CH Daly","year":"2019","unstructured":"Daly CH, Neupane B, Beyene J, Thabane L, Straus SE, Hamid JS (2019) Empirical evaluation of SUCRA-based treatment ranks in network meta-analysis: quantifying robustness using Cohen\u2019s kappa. BMJ Open 9(9):e024625","journal-title":"BMJ Open"},{"issue":"5","key":"13303_CR19","doi-asserted-by":"crossref","first-page":"371","DOI":"10.4097\/kja.21358","volume":"74","author":"E Ahn","year":"2021","unstructured":"Ahn E, Kang H (2021) Concepts and emerging issues of network meta-analysis. Korean J Anesthesiol 74(5):371\u2013382","journal-title":"Korean J Anesthesiol"},{"issue":"1","key":"13303_CR20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T (2014) Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol 14(1):135","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"13303_CR21","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ajic.2018.11.024","volume":"48","author":"K Pogreba-Brown","year":"2020","unstructured":"Pogreba-Brown K, Austhof E, Ellingson K (2020) Methodology minute: an overview of the case\u2013case study design and its applications in infection prevention. Am J Infect Control 48(3):342\u2013344","journal-title":"Am J Infect Control"},{"issue":"1","key":"13303_CR22","first-page":"7","volume":"2","author":"K Pogreba-Brown","year":"2014","unstructured":"Pogreba-Brown K, Ernst K, Harris R (2014) Case-case methods for studying enteric diseases: a review and approach for standardization. OA Epidemiol 2(1):7","journal-title":"OA Epidemiol"},{"issue":"3","key":"13303_CR23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.nrleng.2020.07.022","volume":"38","author":"GX Zhang","year":"2023","unstructured":"Zhang GX, Carrillo-Vico A, Zhang WT, Gao SS, Izquierdo Ayuso G (2023) Incidence and prevalence of multiple sclerosis in China and other Asian countries. Neurolog\u00eda (English Edition) 38(3):159\u2013172","journal-title":"Neurolog\u00eda (English Edition)"},{"issue":"14","key":"13303_CR24","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","volume":"26","author":"C Walton","year":"2020","unstructured":"Walton C, King R, Rechtman L, Kaye W, Leray E, Marrie RA et al (2020) Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition. Mult Scler J 26(14):1816\u20131821","journal-title":"Mult Scler J"},{"key":"13303_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00501","author":"JY Hor","year":"2020","unstructured":"Hor JY, Asgari N, Nakashima I, Broadley SA, Leite MI, Kissani N et al (2020) Epidemiology of neuromyelitis optica spectrum disorder and its prevalence and incidence worldwide. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2020.00501","journal-title":"Front Neurol"},{"key":"13303_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1260358","author":"JY Hor","year":"2023","unstructured":"Hor JY, Fujihara K (2023) Epidemiology of myelin oligodendrocyte glycoprotein antibody-associated disease: a review of prevalence and incidence worldwide. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2023.1260358","journal-title":"Front Neurol"},{"issue":"7","key":"13303_CR27","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1093\/brain\/awz144","volume":"142","author":"M Filippi","year":"2019","unstructured":"Filippi M, Preziosa P, Banwell BL, Barkhof F, Ciccarelli O, De Stefano N et al (2019) Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines. Brain 142(7):1858\u20131875","journal-title":"Brain"},{"issue":"3","key":"13303_CR28","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S1474-4422(15)00393-2","volume":"15","author":"M Filippi","year":"2016","unstructured":"Filippi M, Rocca MA, Ciccarelli O, De Stefano N, Evangelou N, Kappos L et al (2016) MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines. Lancet Neurol 15(3):292\u2013303","journal-title":"Lancet Neurol"},{"key":"13303_CR29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jocn.2023.09.004","volume":"117","author":"B Huang","year":"2023","unstructured":"Huang B, Raglow-DeFranco J, Harel A (2023) James Walker Dawson: his fingers and their historical context. J Clin Neurosci 117:15\u201319","journal-title":"J Clin Neurosci"},{"key":"13303_CR30","volume":"52","author":"B Chen","year":"2021","unstructured":"Chen B, Qin C, Ji S, Tian D, Zhang M, Bu B (2021) Modified models to distinguish central nervous system demyelinating diseases with brain lesions. Mult Scler Relat Disord 52:102965","journal-title":"Mult Scler Relat Disord"},{"issue":"3","key":"13303_CR31","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/jamaneurol.2013.5857","volume":"71","author":"J Kitley","year":"2014","unstructured":"Kitley J, Waters P, Woodhall M, Leite MI, Murchison A, George J et al (2014) Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study. JAMA Neurol 71(3):276\u2013283","journal-title":"JAMA Neurol"},{"issue":"2","key":"13303_CR32","doi-asserted-by":"crossref","first-page":"313","DOI":"10.25259\/JNRP_32_2022","volume":"14","author":"M Salunkhe","year":"2023","unstructured":"Salunkhe M, Gupta P, Singh RK, Elavarasi A, Vibha D, Garg A et al (2023) A comparative analysis of demographic, clinical and imaging features of myelin oligodendrocyte glycoprotein antibody positive, aquaporin 4 antibody positive, and double seronegative demyelinating disorders\u2013an Indian tertiary care center prospective study. J Neurosci Rural Pract 14(2):313","journal-title":"J Neurosci Rural Pract"},{"issue":"9","key":"13303_CR33","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1111\/dmcn.14114","volume":"61","author":"EM Tantsis","year":"2019","unstructured":"Tantsis EM, Prelog K, Alper G, Benson L, Gorman M, Lim M et al (2019) Magnetic resonance imaging in enterovirus-71, myelin oligodendrocyte glycoprotein antibody, aquaporin-4 antibody, and multiple sclerosis-associated myelitis in children. Dev Med Child Neurol 61(9):1108\u20131116","journal-title":"Dev Med Child Neurol"},{"key":"13303_CR34","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.msard.2018.08.008","volume":"25","author":"C Bensi","year":"2018","unstructured":"Bensi C, Marrodan M, Gonz\u00e1lez A, Chertcoff A, Sanz EO, Chaves H et al (2018) Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis. Mult Scler Relat Disord 25:246\u2013250","journal-title":"Mult Scler Relat Disord"},{"issue":"3","key":"13303_CR35","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/brain\/aww350","volume":"140","author":"M Jurynczyk","year":"2017","unstructured":"Jurynczyk M, Geraldes R, Probert F, Woodhall MR, Waters P, Tackley G et al (2017) Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis. Brain 140(3):617\u2013627","journal-title":"Brain"},{"issue":"3","key":"13303_CR36","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1007\/s00415-021-10749-6","volume":"269","author":"H Xie","year":"2022","unstructured":"Xie H, Shao Y, Du J, Song Y, Li Y, Duan R et al (2022) Comparative analysis of clinical and imaging data between patients with myelin oligodendrocyte glycoprotein antibody disease and patients with aquaporin 4 antibody-positive neuromyelitis optica spectrum disorder. J Neurol 269(3):1641\u20131650","journal-title":"J Neurol"},{"issue":"3","key":"13303_CR37","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/ana.25411","volume":"85","author":"L Cacciaguerra","year":"2019","unstructured":"Cacciaguerra L, Meani A, Mesaros S, Radaelli M, Palace J, Dujmovic-Basuroski I et al (2019) Brain and cord imaging features in neuromyelitis optica spectrum disorders. Ann Neurol 85(3):371\u2013384","journal-title":"Ann Neurol"},{"issue":"6","key":"13303_CR38","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1177\/1352458520939008","volume":"27","author":"M-T Cai","year":"2021","unstructured":"Cai M-T, Zheng Y, Shen C-H, Yang F, Fang W, Zhang Y-X et al (2021) Evaluation of brain and spinal cord lesion distribution criteria at disease onset in distinguishing NMOSD from MS and MOG antibody-associated disorder. Mult Scler J 27(6):871\u2013882","journal-title":"Mult Scler J"},{"issue":"6","key":"13303_CR39","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1093\/brain\/awac480","volume":"146","author":"R Cortese","year":"2023","unstructured":"Cortese R, Battaglini M, Prados F, Bianchi A, Haider L, Jacob A et al (2023) Clinical and MRI measures to identify non-acute MOG-antibody disease in adults. Brain 146(6):2489\u20132501","journal-title":"Brain"},{"issue":"6","key":"13303_CR40","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1177\/1352458513506953","volume":"20","author":"S-Y Huh","year":"2014","unstructured":"Huh S-Y, Min J-H, Kim W, Kim S-H, Kim HJ, Kim B-J et al (2014) The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders. Mult Scler 20(6):695\u2013704","journal-title":"Mult Scler"},{"key":"13303_CR41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2377-14-1","volume":"14","author":"M-F Liao","year":"2014","unstructured":"Liao M-F, Chang K-H, Lyu R-K, Huang C-C, Chang H-S, Wu Y-R et al (2014) Comparison between the cranial magnetic resonance imaging features of neuromyelitis optica spectrum disorder versus multiple sclerosis in Taiwanese patients. BMC Neurol 14:1\u20139","journal-title":"BMC Neurol"},{"issue":"1","key":"13303_CR42","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/jcbfm.2015.121","volume":"36","author":"HMA Abraham","year":"2016","unstructured":"Abraham HMA, Wolfson L, Moscufo N, Guttmann CR, Kaplan RF, White WB (2016) Cardiovascular risk factors and small vessel disease of the brain: blood pressure, white matter lesions, and functional decline in older persons. J Cereb Blood Flow Metab 36(1):132\u2013142","journal-title":"J Cereb Blood Flow Metab"},{"issue":"11","key":"13303_CR43","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/j.ajpath.2021.02.007","volume":"191","author":"K Eikermann-Haerter","year":"2021","unstructured":"Eikermann-Haerter K, Huang SY (2021) White matter lesions in migraine. Am J Pathol 191(11):1955\u20131962","journal-title":"Am J Pathol"},{"issue":"3","key":"13303_CR44","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2214\/AJR.18.20888","volume":"213","author":"M-L Wang","year":"2019","unstructured":"Wang M-L, Zhang X-X, Yu M-M, Li W-B, Li Y-H (2019) Prevalence of white matter hyperintensity in young clinical patients. Am J Roentgenol 213(3):667\u2013671","journal-title":"Am J Roentgenol"},{"issue":"10","key":"13303_CR45","doi-asserted-by":"crossref","first-page":"e2128871","DOI":"10.1001\/jamanetworkopen.2021.28871","volume":"4","author":"G Fadda","year":"2021","unstructured":"Fadda G, Alves CA, O\u2019Mahony J, Castro DA, Yeh EA, Marrie RA et al (2021) Comparison of spinal cord magnetic resonance imaging features among children with acquired demyelinating syndromes. JAMA Netw Open 4(10):e2128871","journal-title":"JAMA Netw Open"},{"issue":"11","key":"13303_CR46","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1136\/jnnp-2014-309761","volume":"86","author":"J-W Hyun","year":"2015","unstructured":"Hyun J-W, Kim S-H, Jeong IH, Lee SH, Kim HJ (2015) Bright spotty lesions on the spinal cord: an additional MRI indicator of neuromyelitis optica spectrum disorder? J Neurol Neurosurg Psychiatry 86(11):1280\u20132","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"13303_CR47","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1177\/13524585211060326","volume":"28","author":"J-W Hyun","year":"2022","unstructured":"Hyun J-W, Lee HL, Park J, Kim J, Min J-H, Kim BJ et al (2022) Brighter spotty lesions on spinal MRI help differentiate AQP4 antibody-positive NMOSD from MOGAD. Mult Scler J 28(6):989\u201392","journal-title":"Mult Scler J"},{"key":"13303_CR48","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102481","volume":"46","author":"M Marrod\u00e1n","year":"2020","unstructured":"Marrod\u00e1n M, Hernandez MA, K\u00f6hler AA, Correale J (2020) Differential diagnosis in acute inflammatory myelitis. Mult Scler Relat Disord 46:102481","journal-title":"Mult Scler Relat Disord"},{"issue":"3","key":"13303_CR49","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1177\/1352458515591069","volume":"22","author":"Y Pekcevik","year":"2016","unstructured":"Pekcevik Y, Mitchell CH, Mealy MA, Orman G, Lee IH, Newsome SD et al (2016) Differentiating neuromyelitis optica from other causes of longitudinally extensive transverse myelitis on spinal magnetic resonance imaging. Mult Scler J 22(3):302\u201311","journal-title":"Mult Scler J"},{"issue":"3","key":"13303_CR50","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/1352458513495581","volume":"20","author":"T Yonezu","year":"2014","unstructured":"Yonezu T, Ito S, Mori M, Ogawa Y, Makino T, Uzawa A et al (2014) \u201cBright spotty lesions\u201d on spinal magnetic resonance imaging differentiate neuromyelitis optica from multiple sclerosis. Mult Scler J 20(3):331\u20137","journal-title":"Mult Scler J"},{"issue":"2","key":"13303_CR51","doi-asserted-by":"crossref","first-page":"e233099","DOI":"10.1148\/radiol.233099","volume":"313","author":"C Chien","year":"2024","unstructured":"Chien C, Cruz e Silva V, Geiter E, Meier D, Zimmermann H, Bichuetti DB et al (2024) Aquaporin-4 immunoglobulin G\u2013seropositive neuromyelitis optica spectrum disorder MRI characteristics: data analysis from the International real-world PAMRINO study cohort. Radiology 313(2):e233099","journal-title":"Radiology"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13303-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13303-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13303-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:35:43Z","timestamp":1760524543000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13303-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,7]]},"references-count":51,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["13303"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13303-w","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,7]]},"assertion":[{"value":"3 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"SA.B has received compensation for participation in an organising committee for an educational symposium from Roche. SA.B has received consultancy fees from Moderna. The remaining authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"560"}}